The Company, based on its current plans and initiatives, continues to expect full year 2023 revenue in the range of $95-98 million.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AKYA:
- Akoya Reports Record Revenue in the Third Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
- Akoya Biosciences to showcase spatial biology 2.0 solutions
- Akoya Biosciences to Showcase New Spatial Biology 2.0 Solutions and Spatial Phenotyping Data at SITC 2023
- Akoya Biosciences price target lowered to $8 from $15 at Morgan Stanley
- Akoya Biosciences announces publication on ultrahigh-plex spatial phenotyping
